Loading…
Attending this event?
Wednesday, June 19 • 8:00am - 9:00am
#306: Which Clinical Outcome Assessment to Choose: Questionnaire or Sensor? Time to Align an Endpoint Selection Framework

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Component Type: Forum
Level: Intermediate
CE: ACPE 1.00 Knowledge UAN: 0286-0000-24-627-L04-P; CME 1.00; RN 1.00

Questionnaires, standardized tasks, and DHTs can measure similar outcomes which complicates endpoint selection. This forum discusses a framework to align ontologies for actively-collected and passively-monitored COAs to streamline endpoint strategy

Learning Objectives

Identify biomarkers from actively collected and passively-monitored COAs building upon regulatory definitions; Determine a framework to align ontologies for these measure types enabling rapid, evidence-based, and fit-for-purpose measure selection using case study examples.

Chair

Caprice Sassano, MPH

Speaker

Panelist
Roya Sherafat-Kazemzadeh, MD, PhD

Panelist
Megan Parisi, MS

Panelist
Thomas Switzer, MEd


Speakers
CS

Caprice Sassano

Research and Data Products - Applied Sciences, HumanFirst, United States
RS

Roya Sherafat-Kazemzadeh

Scientific Director, Mapi Research Trust, France
Dr. Roya Sherafat is a trained physician and holds dual PhDs in epidemiology and health policy. Roya has over a decade experience in clinical research in the field of obesity and cardiometabolic health specifically on profiling risk factors, adverse cardiometabolic outcomes, and heterogeneity... Read More →
avatar for Megan Parisi

Megan Parisi

Patient Solutions Lead, Syneos Health, United States
Megan Parisi, MS, CCRP, is a Patient Solutions Lead at Syneos Health where she curates patient centric strategies for implementation into clinical trials across all phases of development. She innovates in patient and site focused trial design, focusing on decentralized and digital... Read More →
avatar for Thomas Switzer

Thomas Switzer

Principal Digital Health Scientist, Genentech, A Member of the Roche Group, United States
Tom is a Principal Scientist and Digital Health Lead in Genentech's Research and Early Development Informatics group.  His current focus is on developing technology platforms supporting molecule teams across the early development portfolio.  Tom has over 24 years of clinical development... Read More →

Wednesday June 19, 2024 8:00am - 9:00am PDT
Room 15AB San Diego Convention Center 111 W Harbor Drive, San Diego, CA 92101 USA
  05: Patient-Focused Drug Dev, Forum